Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-01
2008-07-01
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S082000
Reexamination Certificate
active
07393860
ABSTRACT:
The compound (7R,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydro-imidazo-[1,2-h] [1,7] naphthyridine inhibits the secretion of gastric acid.
REFERENCES:
patent: 4468400 (1984-08-01), Gold et al.
patent: 5112834 (1992-05-01), Senn-Bilfinger
patent: 6197783 (2001-03-01), Senn-Bilfinger et al.
patent: 6436953 (2002-08-01), Senn-Bilfinger
patent: 6696460 (2004-02-01), Senn-Bilfinger
patent: 0 299 470 (1989-01-01), None
patent: 89/00570 (1989-01-01), None
patent: 95/27714 (1995-10-01), None
patent: 96/03404 (1996-02-01), None
patent: 98/42707 (1998-10-01), None
Kaminski, J.J., et al., “Antiulcer Agents. 1. Gastric Antisecretory and Cytoprotective Properties of Substituted Imidazo[1,2-a]pyridines”,J. Med. Chem., vol. 28, pp. 876-892, (1985).
Altana Pharma AG
Desai Rita J
Goldberg Joshua B.
McGee Sheldon M.
The Nath Law Group
LandOfFree
Tetrahydropyridoethers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydropyridoethers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydropyridoethers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2812095